References
- Davis GL, Dempster J, Meler JD, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ Med Cent). 2008; 21(3):266–280.
- Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–91.e1.
- Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–1314.
- Karakousis ND, Papatheodoridi A, Chatzigeorgiou A, et al. Cellular senescence and hepatitis b related hepatocellular carcinoma: an intriguing link. Liver Int. 2020;40(12):2917–2927.
- Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6(9):674–687.
- Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Clin Pract Gastroenterol Hepatol. 2010;7(8):59–69.
- Hara Y, Hino K, Okuda M, et al. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species. J Gastroenterol. 2006;41(3):257–268.
- Singh AK, Kumar R, Pandey AK. Hepatocellular carcinoma: causes, mechanism of progression and biomarkers. Curr Chem Genom Transl Med. 2018;12(1):9–26.
- Verna L. N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. Pharmacol Ther. 1996;71(1–2):57–81.
- Tolba R, Kraus T, Liedtke C, et al. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49(1_suppl):59–69.
- Blum HE. Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol. 2005;11:7391–7400.
- Ahmed OM, Ahmed AA, Fahim HI, et al. Quercetin and naringenin abate diethylnitrosamine/acetylaminofluorene-induced hepatocarcinogenesis in Wistar rats: the roles of oxidative stress, inflammation and cell apoptosis. Drug Chem Toxicol. 2019;1–12. DOI:10.1080/01480545.2019.1683187
- Subramaniam N, Kannan P, K A TD. Hepatoprotective effect of boldine against diethylnitrosamine-induced hepatocarcinogenesis in wistar rats. J Biochem Mol Toxicol. 2019;33(12):e22404.
- Xu M, Zhao Q, Shao D, et al. Chenodeoxycholic acid derivative HS-1200 inhibits hepatocarcinogenesis and improves liver function in diethylnitrosamine-exposed rats by downregulating MTH1. Biomed Res Int. 2017;2017:1465912.
- Hussein UK, Mahmoud HM, Farrag AG, et al. Chemoprevention of diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in rats by sulfated polysaccharides and aqueous extract of ulva lactuca. Integr Cancer Ther. 2015;14(6):525–545.
- Lee JS, Synytsya A, Kim HB, et al. Purification, characterization and immunomodulating activity of a pectic polysaccharide isolated from Korean mulberry fruit oddi (morus alba L.). Int Immunopharmacol. 2013;17(3):858–866.
- Jin YS, Sa JH, Shim TH, et al. Hepatoprotective and antioxidant effects of morus bombycis koidzumi on CCl4-induced liver damage. Biochem Biophys Res Commun. 2005;329(3):991–995.
- Yuan Q, Zhao L. The mulberry (morus alba L.) Fruit—A review of characteristic components and health benefits. J Agric Food Chem. 2017;65(48):10383–10394.
- Chen C, You L-J, Abbasi AM, et al. Characterization of polysaccharide fractions in mulberry fruit and assessment of their antioxidant and hypoglycemic activities in vitro. Food Funct. 2016;7(1):530–539.
- Zhou X, Deng Q, Chen H, et al. Characterizations and hepatoprotective effect of polysaccharides from mori fructus in rats with alcoholic-induced liver injury. Int J Biol Macromol. 2017;102:60–67.
- Liu CJ, Lin JY. Anti-inflammatory and anti-apoptotic effects of strawberry and mulberry fruit polysaccharides on lipopolysaccharide-stimulated macrophages through modulating pro-/anti-inflammatory cytokines secretion and Bcl-2/Bak protein ratio. Food Chem Toxicol. 2012;50(9):3032–3039.
- Shin BR, Kim HS, Yun MJ, et al. Promoting effect of polysaccharide isolated from Mori fructus on dendritic cell maturation. Food Chem Toxicol. 2013;51:411–418.
- Liu H, Zhang H, Fan H, et al. The preventive effect of Cuscutae Semen polysaccharide on bone loss in the ovariectomized rat model. Biomed Pharmacothe. 2020;130:110613.
- Saha SK, Brewer CF. Determination of the concentrations of oligosaccharides, complex type carbohydrates, and glycoproteins using the phenol-sulfuric acid method. Carbohydr Res. 1994;254:157–167.
- Gan C-Y, Abdul Manaf NH, Latiff AA. Optimization of alcohol insoluble polysaccharides (AIPS) extraction from the Parkia speciosa pod using response surface methodology (RSM). Carbohydr Polym. 2010;79(4):825–831.
- Dodgson KS, Price RG. A note on the determination of the ester sulphate content of sulphated polysaccharides. Biochem J. 1962;84(1):106–110.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(1–2):248–254.
- Mahmoud AM, Zaki AR, Hassan ME, et al. Commiphora molmol resin attenuates diethylnitrosamine/phenobarbital-induced hepatocarcinogenesis by modulating oxidative stress, inflammation, angiogenesis and Nrf2/ARE/HO-1 signaling. Chem Biol Interact. 2017;270:41–50.
- Hooshmand S, Mahdinezhad MR, Taraz Jamshidi S, et al. Morus nigra L. extract prolongs survival of rats with hepatocellular carcinoma. Phytother Res. 2021;35(6):3365–3376.
- Bodzin AS. Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome. World J Hepatol. 2015;7(9):1157–1167.
- Gomaa AI. Recent advances in multidisciplinary management of hepatocellular carcinoma. World J Hepatol. 2015;7(4):673–687.
- Xie JH, Jin ML, Morris GA, et al. Advances on bioactive polysaccharides from medicinal plants. Crit Rev Food Sci Nutr. 2016;56(Suppl sup1):S60–84.
- Jiao R, Liu Y, Gao H, et al. The anti-oxidant and antitumor properties of plant polysaccharides. Am J Chin Med. 2016;44(3):463–488.
- Sivaramakrishnan V, Shilpa PN, Praveen Kumar VR, et al. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact. 2008;171(1):79–88.
- Hegazy RR, Mansour DF, Salama AA, et al. Regulation of PKB/Akt-pathway in the chemopreventive effect of lactoferrin against diethylnitrosamine-induced hepatocarcinogenesis in rats. Pharmacol Rep. 2019;71(5):879–891.
- Krishnan P, Sundaram J, Salam S, et al. Citral inhibits N-nitrosodiethylamine-induced hepatocellular carcinoma via modulation of antioxidants and xenobiotic-metabolizing enzymes. Environ Toxicol. 2020;35(9):971–981.
- Chen T, Dai X, Dai J, et al. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death Dis. 2020;11(10):822.
- Sakai M, Muramatsu M. Regulation of glutathione transferase P: a tumor marker of hepatocarcinogenesis. Biochem Biophys Res Commun. 2007;357(3):575–578.
- Su Z, Yang Z, Xu Y, et al. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14(1):48.
- Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6(2):99–104.
- Kashyap D, Sharma A, Tuli HS, et al. Molecular targets of celastrol in cancer: recent trends and advancements. Crit Rev Oncol Hematol. 2018;128:70–81.
- Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res off J Am Assoc Cancer Res. 2009;15(4):1126–1132.
- Ulasli SS, Celik S, Gunay E, et al. Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene. Asian Pac J Cancer Prev. 2013;14(10):6159–6164.
- Huang Y, Yin M, Pan L, et al. Solanum nigrum polysaccharide inhibits tumor growth in H22-bearing mice through regulation of caspase-3 and bcl-2. J Cancer Res Ther. 2018;14(8):S232–s6.
- Yang YM, Kim SY, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Seminars in liver disease 2019; 39:26–42.
- Wang W, Nag SA, Zhang R. Targeting the NFκB signaling pathways for breast cancer prevention and therapy. Curr Med Chem. 2015;22(2):264–289.
- Sokolova O, Naumann M. NF-κB signaling in gastric cancer. Toxins (Basel). 2017;9(4):119.
- Marquardt JU, Gomez-Quiroz L, Arreguin Camacho LO, et al. Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J Hepatol. 2015;63(3):661–669.
- Saber S, Ghanim AMH, El-Ahwany E, et al. Novel complementary antitumour effects of celastrol and metformin by targeting IκBκB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis. Cancer Chemother Pharmacol. 2020;85(2):331–343.
- Uehara T, Pogribny IP, Rusyn I. The DEN and CCl4 -Induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma. Curr Protoc Pharmacol. 2014;66(1):1–10. 30.
- Nakabeppu Y. Regulation of intracellular localization of human MTH1, OGG1, and MYH proteins for repair of oxidative DNA damage. Progress in nucleic acid research and molecular biology. 2001;68:75–94.
- Teoh NC, Dan YY, Swisshelm K, et al. Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice. Hepatology. 2008;47(6):2078–2088.
- Hua X, Sanjiv K, Gad H, et al. Karonudib is a promising anticancer therapy in hepatocellular carcinoma. Ther Adv Med Oncol. 2019;11:1758835919866960.